Cefoperazone free acid
CAS: 62893-19-0
Ref. 3D-AC64974
10g | 136,00 € | ||
25g | 217,00 € | ||
50g | 346,00 € | ||
100g | 452,00 € | ||
250g | 723,00 € |
Información del producto
- (6R,7R)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2S)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, [6R-[6α,7β(R*)]]-
- Biocefazon
- Cefob
- Cefobid
- Cefoperazine
- Ver más sinónimos
- Cefoperazon
- Cefoperazone,sodium salt
- Cefoperazono
- Cefozon
- Cephaperazon
- Medocef
- sodium 7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Cefoperazone
Cefoperazone is a broad-spectrum antibiotic that inhibits bacterial growth by binding to the 50S ribosomal subunit. It is used to treat a variety of bacterial infections, including infections caused by Streptococcus pneumoniae and Haemophilus influenzae. Cefoperazone has been shown to inhibit the BCR-ABL kinase in vitro and in vivo, which may be useful for leukemia treatment. The optimum concentration of cefoperazone for treating an infection is determined using a chemiluminescence method. This antibiotic binds to penicillin-binding proteins (PBPs) on the surface of bacteria, preventing them from synthesizing peptidoglycan. The mechanism of action for cefoperazone differs from other antibiotics because it does not inhibit cell wall synthesis or protein synthesis.
Propiedades químicas
Consulta técnica sobre: 3D-AC64974 Cefoperazone free acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.